1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Posters

Showing 1,267 results.

Thumbnail for Light Chain Amyloidosis in Waldenstrφm Macroglobulinemia/Lymphoplasmacytic Lymphoma: Treatment Strategies and Outcomes of 74 Cases

IBCL - 290

Light Chain Amyloidosis in Waldenstrφm Macroglobulinemia/Lymphoplasmacytic Lymphoma: Treatment Strategies and Outcomes of 74 Cases

Nicol? Danesin

Poster Presenter: Nicol? Danesin

Thumbnail for Patterns of Treatment Utilization and Sequencing Across Lines of Therapy in Waldenstrφm Macroglobulinemia: Real-World Evidence From the United States

IBCL - 291

Patterns of Treatment Utilization and Sequencing Across Lines of Therapy in Waldenstrφm Macroglobulinemia: Real-World Evidence From the United States

Jorge J Castillo

Poster Presenter: Jorge J Castillo

Video

Thumbnail for Weekly Hypomethylating Agent and Venetoclax Combination Therapy in Myeloid Neoplasms: A Real-World Single-Center Experience in an Older, High-Comorbidity Population

AML - 292

Weekly Hypomethylating Agent and Venetoclax Combination Therapy in Myeloid Neoplasms: A Real-World Single-Center Experience in an Older, High-Comorbidity Population

Mahmood Aldapt

Poster Presenter: Mahmood Aldapt

Thumbnail for CD10 Loss Defines a Biologically Distinct and Extranodal-Enriched Subset of Follicular Lymphoma: A Systematic Review and Meta-Analysis

IBCL - 293

CD10 Loss Defines a Biologically Distinct and Extranodal-Enriched Subset of Follicular Lymphoma: A Systematic Review and Meta-Analysis

Adarsh Vardhan Tangella

Poster Presenter: Adarsh Vardhan Tangella

$Thumbnail for Micro-Costing Analysis of Adverse Events of Pediatric Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Therapy in the United States$

ALL - 294

Micro-Costing Analysis of Adverse Events of Pediatric Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Therapy in the United States

Marleni Torres Nunez

Poster Presenter: Marleni Torres Nunez

Thumbnail for Relapse-Mortality Trade-off Between Autologous and Allogeneic Stem Cell Transplantation in Relapsed Follicular lymphoma and Marginal zone lymphoma: A Registry-Based Proportional Meta-Analysis

IBCL - 295

Relapse-Mortality Trade-off Between Autologous and Allogeneic Stem Cell Transplantation in Relapsed Follicular lymphoma and Marginal zone lymphoma: A Registry-Based Proportional Meta-Analysis

Adarsh Vardhan Tangella

Poster Presenter: Adarsh Vardhan Tangella

Thumbnail for ADAM17-Driven NKG2D Ligand Shedding Defines a Leukemia-Intrinsic Immune Evasion Program That Predicts Venetoclax Resistance and Reveals MEK and PI3K As Therapeutic Vulnerabilities in AML

AML - 296

ADAM17-Driven NKG2D Ligand Shedding Defines a Leukemia-Intrinsic Immune Evasion Program That Predicts Venetoclax Resistance and Reveals MEK and PI3K As Therapeutic Vulnerabilities in AML

Abdelrahman Masheh

Poster Presenter: Abdelrahman Masheh

$Thumbnail for Correlation Among IL-8, TNF-α, and Overall Survival in Imetelstat-Treated Patients With Myelofibrosis Relapsed or Refractory to a Janus Kinase Inhibitor (JAKi) in the IMbark Trial$

MPN - 298

Correlation Among IL-8, TNF-α, and Overall Survival in Imetelstat-Treated Patients With Myelofibrosis Relapsed or Refractory to a Janus Kinase Inhibitor (JAKi) in the IMbark Trial

John Mascarenhas

Poster Presenter: John Mascarenhas

Thumbnail for Cardiovascular Toxicity, Bleeding, and Second Primary Malignancy Risk With Covalent vs Noncovalent BTK Inhibitors in CLL: A Systematic Review and Meta-Analysis

CLL - 299

Cardiovascular Toxicity, Bleeding, and Second Primary Malignancy Risk With Covalent vs Noncovalent BTK Inhibitors in CLL: A Systematic Review and Meta-Analysis

Elias Tayar

Poster Presenter: Elias Tayar